Systematic analysis of aberrances of ferroptosis reveals its potential functional roles in cancer

Zekun Liu,Qi Zhao,Zhixiang Zuo,Shu-Qiang Yuan,Kai Yu,Qingfeng Zhang,Xiaolong Zhang,Hui Sheng,Huai-Qiang Ju,Han Cheng,Feng Wang,Rui-Hua Xu,Ze-Xian Liu
DOI: https://doi.org/10.1101/765826
IF: 5.8
2020-01-01
iScience
Abstract:Ferroptosis is a type of cell death that related to cancer, however, the characteristics of ferroptosis in cancers are still uncertain. Based on the data in The Cancer Genome Atlas, we found that most ferroptosis regulator genes (FRGs) were differentially expressed in tumors, copy number alterations (CNA) and DNA methylation contributed to their aberrant expression. We established the ferroptosis potential index (FPI) to reveal the functional roles of ferroptosis and noticed that the FPI was higher in tumors than in normal tissues in most cancers, and was associated with subtypes and clinical features. The FPI was negatively correlated with several metabolism pathways but positively associated with several important metastasis-related pathways and immune-related pathways. Higher FPI predicted worse prognosis in several tumors, while FPI and FRGs impacted drug sensitivity. Our study presents a systematical analysis of ferroptosis and its regulatory genes, and highlights the potential of ferroptosis-based cancer therapy.
What problem does this paper attempt to address?